Contrast-enhanced Ultrasound Evaluation of Chemoembolization

NCT02764801 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

131

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Chemoembolization, Therapeutic

Interventions

DRUG: Ultrasound contrast agent (Contrast-enhanced ultrasound)
DEVICE: Logiq E9 Scanner (Contrast-enhanced ultrasound)

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]